Cross-resistance to cis-diamminedichloroplatinum(II) of a multidrug-resistant lymphoma cell line associated with decreased drug accumulation and enhanced DNA repair
- 1 June 1996
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 305 (1-3) , 213-222
- https://doi.org/10.1016/0014-2999(96)00168-9
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Use of a monoclonal antibody to detect DNA damage caused by the anticancer drug cis‐diamminedichloroplatinum (II) in vivo and in vitroFEBS Letters, 1994
- Enhanced excision repair of DNA damage due to cis-diamminedichloroplatinum(II) in resistant cervix carcinoma HeLa cellsEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Apparent alterations in the early stage of excision repair of UV-induced DNA damages in a HeLa mutant cell line that is resistant to genotoxic stressesMutation Research Letters, 1993
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- UV damage-specific DNA-binding protein in xeroderma pigmentosum complementation group EBiochemical and Biophysical Research Communications, 1991
- Repair of pyrimidine dimer ultraviolet light photoproducts by human cell extractsBiochemistry, 1989
- Complementation of the xeroderma pigmentosum DNA repair defect in cell-free extractsCell, 1988
- Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA PolymeraseScience, 1988
- Aphidicolin inhibits eukaryotic DNA replication and repair — Implications for involvement of DNA polymerase α in both processesBiochemical and Biophysical Research Communications, 1979
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976